Quantifying retention during pre-antiretroviral treatment in a large urban clinic in Uganda

BMC Infectious Diseases

Table 1 Factors associated with lost to program after enrolment into HIV care

	All patients ¹			Patients with CD4 count test performed ² (N = 17057)
	(N = 19774)			Patients with CD4 count test performed ² (N = 17057)
Variable	Crude HR (95 % CI)		P-value	AHR 95 % (CI)	P-value
Females	1.00			1.00
Males	1.19 (1.12 – 1.26)		<0.001	1.23 (1.15– 1.31)	<0.001
Age, 5 year increase	0.98 (0.96 – 0.99)		0.006	0.99 (0.97– 1.00)	0.183
WHO Stage^a I-II	1.00			1.00
III-IV	1.20 (1.13 – 1.27)		<0.001	1.29 (1.21 – 1.38)	<0.001
Year of enrolment
2005 - 2008	1.00			1.00
2009 - 2011	0.70 (0.64 – 0.75)		<0.001	1.71 (0.65 – 0.77)	<0.001
2012 - 2013	0.39 (0.31 – 0.52)		<0.001	0.19 (0.12 – 0.29)	<0.001
CD4 count 50 cell/μL increase		N/A		1.03 (1.02 – 1.03)	<0.001

1 -Predictor of LTP at any stage from enrolment into care for all patients
2 -Predictor of LTP at any stage from enrolment into care among patients with CD4 count test performed
a. 2120 patients with missing data on WHO clinical stage
N/A: not applicable

ISSN: 1471-2334